Junshi Biosciences Announces Collaboration with Dr. Reddy's

SHANGHAI, China, May 07, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) announced a...

Related Keywords

Uruguay ,Colombia ,Mexico ,Argentina ,Australia ,Brazil ,Chile ,Guangzhou ,Guangdong ,China ,Bombay ,Maharashtra ,India ,New Zealand ,Suzhou ,Jiangsu ,Hyderabad ,Andhra Pradesh ,United Kingdom ,Maryland ,United States ,Beijing ,Uzbekistan ,Panama ,Peru ,San Francisco ,California ,South Africa ,Shanghai ,America ,Chinese ,Junshi Biosciences ,Junshi Bioscience ,Zhi Li ,Bombay Stock Exchange ,Regulatory Agency ,Ir Team ,Reddy Laboratories Limited Dr ,Pr Team ,National Stock Exchange Of India ,Shanghai Junshi Biosciences Co Ltd ,Good Health Cant Wait ,York Stock Exchange ,New York Stock Exchange ,Drug Administration ,National Reimbursement Drug List ,European Medicines Agency ,Laboratories Limited ,Latin America ,For Global ,Chief Executive Officer ,Branded Markets ,Emerging Markets ,Southeast Asia ,Biologics License Application ,Breakthrough Therapy ,Fast Track ,Orphan Drug ,National Stock Exchange ,Sustainability Report ,Emergency Use Authorizations ,Hong Kong Stock Exchange 1877 Hk ,